Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …

Background Bloodstream infections (BSIs) produced by antibiotic-resistant bacteria (ARB)
cause a substantial disease burden worldwide. However, most estimates come from high …

Delayed discharge for non-clinical reasons (bed-blocking) is characteristic of pathologies
associated with ageing, loss of functional capacity and dependence such as stroke. The …

The aim of this analysis was to assess the costs associated with the hospitalizations of
persons with diabetes in a Romanian public hospital. We performed a retrospective “top …

Background: Health policies in transitioning health systems are rarely informed by the
economic burden of disease due to scanty access to data. This study aimed to estimate …

Cardiovascular diseases (CVDs) represent the leading cause of death globally. Romania
recorded the highest mortality rate due to CVDs in the EU in 2022, with 162,984 deaths …

The cost-effectiveness of Cerebrolysin as an add-on therapy for moderate–severe acute
ischemic stroke is a topic that remains understudied. This study aims to address this gap by …

Background: The Improved Health Care in Neurology and Psychiatry—Longer Life (IHCNP)
study was an 18-month prospective, observational, non-interventional research study …

Post-stroke spasticity frequently occurs in patients with stroke, and there is a need for more
quality-of-life assessments for different therapies. We evaluated for the first time in Romania …

Evidence of the short-term effects of ambient sulfur dioxide (SO2) exposure on the economic
burden of ischemic stroke is limited. This study aimed to explore the association between …